Gsa Capital Partners LLP Exact Sciences Corp Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $251,859 - $346,223	-2,791 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$93.66 - $139.27 $261,405 - $388,702	2,791 New	2,791 $347,000
Q2 2019 Aug 06, 2019	SELL	$89.51 - $118.04 $1.51 Million - $1.98 Million	-16,815 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $747,726 - $1.16 Million	12,064 Added 253.93%	16,815 $1.46 Million
Q4 2018 Feb 12, 2019	BUY	$56.04 - $82.66 $266,246 - $392,717	4,751 New	4,751 $300,000
Q3 2018 Nov 13, 2018	SELL	$48.29 - $80.6 $515,882 - $861,049	-10,683 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$37.84 - $69.96 $93,729 - $173,290	2,477 Added 30.19%	10,683 $639,000
Q1 2018 May 11, 2018	BUY	$39.82 - $57.53 $326,762 - $472,091	8,206 New	8,206 $331,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.